Technical Analysis for ORIC - Oric Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 23.01 -0.39% -0.09
ORIC closed up 5.05 percent on Thursday, April 22, 2021, on approximately normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical ORIC trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish -0.39%
Down 3 Days in a Row Weakness 9.47%
Wide Bands Range Expansion 7.88%
MACD Bullish Signal Line Cross Bullish 5.02%
NR7 Range Contraction 5.02%
Wide Bands Range Expansion 5.02%
Up 3 Days in a Row Strength 5.02%
Oversold Stochastic Weakness 5.02%
Slingshot Bearish Bearish Swing Setup 8.08%
Multiple of Ten Bullish Other 8.08%
Older End-of-Day Signals for ORIC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
2x Volume Pace about 1 hour ago
1.5x Volume Pace about 1 hour ago
Down 2 % about 1 hour ago
Down 1% about 1 hour ago
Up 3% about 1 hour ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. Its lead product candidate is ORIC-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors. The company's second product candidate is ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. It is also developing multiple precision medicines targeting other cancer resistance mechanisms. The company was founded in 2014 and is headquartered in South San Francisco, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Solid Tumors Immunotherapy Treatment Of Cancer Oncology Cancers Cancer Treatments Chemotherapy Occupational Safety And Health Antineoplastic Drugs Specialty Drugs Precision Medicine Cancer Therapeutics Treatment Of Cancers Cd73

Is ORIC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 40.81
52 Week Low 18.6
Average Volume 233,872
200-Day Moving Average 27.49
50-Day Moving Average 28.13
20-Day Moving Average 22.37
10-Day Moving Average 21.27
Average True Range 1.91
ADX 45.07
+DI 17.18
-DI 23.41
Chandelier Exit (Long, 3 ATRs ) 20.58
Chandelier Exit (Short, 3 ATRs ) 24.68
Upper Bollinger Band 25.25
Lower Bollinger Band 19.50
Percent B (%b) 0.63
BandWidth 25.69
MACD Line -1.74
MACD Signal Line -2.18
MACD Histogram 0.4424
Fundamentals Value
Market Cap 822.2 Million
Num Shares 35.6 Million
EPS -99999.99
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 0.00
Price-to-Book 6.59
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.49
Resistance 3 (R3) 26.38 25.13 25.93
Resistance 2 (R2) 25.13 24.27 25.19 25.74
Resistance 1 (R1) 24.12 23.74 24.63 24.23 25.55
Pivot Point 22.87 22.87 23.13 22.93 22.87
Support 1 (S1) 21.86 22.01 22.37 21.97 20.65
Support 2 (S2) 20.61 21.48 20.67 20.46
Support 3 (S3) 19.60 20.61 20.28
Support 4 (S4) 19.71